A Novel Study Evaluating Patients Awaiting Total Hip Arthroplasty (PRIORITEES)

NCT06178185 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 240

Last updated 2023-12-20

No results posted yet for this study

Summary

Hip replacements are one of the NHS's highest volume procedures, with \~14,000 operations per month before the onset of the COVID-19 pandemic. Delays to surgery can have significant implications; meaning increasing levels of pain and worsening quality of life.

As of January 2021, following the initial waves of the COVID-19 pandemic, 58,000 people had waited an average of 25 additional weeks for their total hip replacement.

The results of the study will hopefully help treating clinicians identify patients in whom there may be further deterioration if surgery is significantly delayed.

Conditions

  • Hip Replacement

Sponsors & Collaborators

  • Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust

    lead OTHER_GOV

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-27
Primary Completion
2024-06-27
Completion
2024-06-27

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06178185 on ClinicalTrials.gov